Global Pertussis Cases Surge to Over 941,000 in 2024
A significant rise in pertussis cases highlights the urgent need for updated vaccination strategies as the Global Pertussis Initiative proposes a new framework.
Global pertussis cases increased nearly sixfold from 163,000 in 2023 to over 941,000 in 2024.
The Global Pertussis Initiative has introduced a flexible, risk-based vaccination framework for countries.
An updated WHO position paper is essential to reflect the latest epidemiological data and vaccination needs.
In a concerning development, global cases of pertussis have surged dramatically, reaching over 941,000 in 2024, a nearly sixfold increase from approximately 163,000 reported in 2023. This resurgence, which follows a period of low incidence during the COVID-19 pandemic, underscores the pressing need for an updated vaccination strategy as outlined in the 2015 WHO position paper.
The Global Pertussis Initiative (GPI), comprising over 350 experts from 68 countries, has recognized the changing landscape of pertussis epidemiology and has proposed a flexible, risk-based framework. This framework aims to assist nations in adapting their vaccination strategies according to local disease patterns and available resources. The primary goal remains to prevent severe disease and mortality in infants under six months through maternal vaccination and timely infant immunization.
Recent data highlights the critical situation, with provisional figures from the USA indicating that infants under six months had the highest incidence rates and hospitalizations. Vaccination during pregnancy is emphasized as the most effective strategy to provide early protection to newborns. The GPI's framework suggests a series of sequential vaccination strategies, including early-year boosters and school-entry vaccinations, tailored to each country's specific epidemiological context.
The implications of these findings extend beyond immediate health concerns, affecting public health policy and vaccination programs globally. The WHO's current guidelines, established in 2015, must be revisited to incorporate the latest evidence and address the challenges posed by vaccine hesitancy and access disparities. The pandemic has exacerbated existing gaps in vaccination coverage, with millions of children missing essential doses.
Looking ahead, the GPI calls for a comprehensive review of the WHO position paper to ensure that vaccination policies align with current data and effectively address the resurgence of pertussis. Future actions will focus on enhancing vaccine supply chains, educating healthcare providers, and improving public awareness to combat vaccine hesitancy, thereby safeguarding vulnerable populations against this preventable disease.
